ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Chemed Corp

Chemed Corp (CXM)

505.00
-5.00
( -0.98% )
Updated: 09:35:24
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
505.00
Bid
510.00
Ask
515.00
Volume
3
505.00 Day's Range 505.00
480.00 52 Week Range 570.00
Previous Close
510.00
Open
505.00
Last Trade
3
@
505
Last Trade Time
04:42:00
Average Volume (3m)
15
Financial Volume
-
VWAP
-

CXM Latest News

Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Ther

SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) reported today that its Cardium Biologics division provided an update on plans for the continuing commercial...

Cardium to Launch MedPodium(TM) Product Line Initially Covering Six New Advanced Foot Care Products for Podiatry Patients to Com

SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to launch a new premium advanced skin care product line to promote foot health and comfort...

Cardium Reports on Exchange Listing With NYSE AMEX

SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) reported that it received notification from the staff of the company's current listing exchange indicating that...

Cardium Reports on Recent Norwegian Study Revealing That History of Foot Ulcers Is a Significant Predictor of Mortality in Diabe

SAN DIEGO, Dec. 16 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported on recent clinical findings published in the December issue of Diabetes Care showing an increase...

Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development

SAN DIEGO, Dec. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) announced a presentation titled, "Phase 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic...

Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable

SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) announced today that its wholly-owned subsidiary, Tissue Repair Company, submitted a 510(k) premarket...

Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments

SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported its financial results for its third quarter ended September 30, 2009, and on recent developments...

Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressu

SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA...

Cardium Completes $6.0 Million Registered Direct Offering

SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it has completed its previously announced $6.0 million registered direct offering of...

Cardium Announces $6.0 Million Registered Direct Offering

SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced a registered direct offering of common stock to selected investors for aggregate gross proceeds...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-10-1.941747572825155155057514.75DE
45150051550022501.65841584DE
12-45-8.1818181818255057048015514.92732558DE
26153.061224489849057048012513.02020202DE
52-30-5.6074766355153557048011512.57914339DE
156-30-5.6074766355153557048011512.57914339DE
260-30-5.6074766355153557048011512.57914339DE

CXM - Frequently Asked Questions (FAQ)

What is the current Chemed share price?
The current share price of Chemed is 505.00 €
What is the 1 year trading range for Chemed share price?
Chemed has traded in the range of 480.00 € to 570.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZK7Conduit Pharmaceuticals Inc
0.131 €
(87.14%)
14.8k
7KOCullinan Metals Corp
0.0216 €
(80.00%)
1.5k
Y31Infinitii Ai Inc
0.075 €
(64.84%)
11.27M
RV0Torrent Gold Inc
0.138 €
(55.06%)
5.05k
A8DAb Science
1.86 €
(45.09%)
45.48k
L7C2Windfall Geotek Inc
0.003 €
(-64.71%)
1.32k
E3O1Nexoptic Technology Corp
0.0075 €
(-51.61%)
742
LL3PanGenomic Health Inc
0.0766 €
(-39.40%)
400
0PV2Moovly Media Inc
0.003 €
(-33.33%)
140.76k
POTAPortofino Resources Inc
0.006 €
(-30.23%)
10.08k
Y31Infinitii Ai Inc
0.075 €
(64.84%)
11.27M
D7GNel ASA
0.2735 €
(1.71%)
3.45M
3CPXiaomi Corporation
4.2795 €
(-5.04%)
3.39M
76M0Realbotix Corp
0.414 €
(7.81%)
3.3M
PF8European Lithium Limited
0.0286 €
(6.72%)
3M

Discussion

View Full Feed
jour_trader jour_trader 5 minutes ago
Thanks. Meant to provide that months ago and just didn't have time to dig in. Some cases that had a couple similar patents infringed (Amneal) were settled. Docs are behind a paywall so haven't seen specific details there. 
ELTP
jimmybob jimmybob 5 minutes ago
$TDOC back over its 200dma - it is still January last I checked so January effect is still in effect

I think that rhymes btw
TDOC
FeMike FeMike 6 minutes ago
Why do you need to lie to disparage the presentation?

I don't.

The presentation does that for itself.

Presenting the failed original primary endpoint data as the first results slide was an egregious offense to shareholders. Should never have happened.
NWBO
Doubledown75 Doubledown75 6 minutes ago
CFTC chair Benham resigned;)
AABB
doc2016 doc2016 6 minutes ago
the nvda miniaturized supercomputer named thor is n the cloud or on the device. 'and/or'?does drive os send realtime data to the learning module during the course of operation?
call winning, thor seems like a very much more powerful mpc 555 telematics device. it likely has facets of the vc
Teddytropics Teddytropics 6 minutes ago
That's the plan..

Come on the SEC...

Allow them run...
CNNA
rbtree rbtree 6 minutes ago
15.92!!!!!!!!!!!!!!!!!!!! 7 minutes after open!
ENVX
DiscoverGold DiscoverGold 6 minutes ago
Today Disney (Walt) Company. (DIS) is the best performer in the DJIA
By: Thom Hartle | January 7, 2025

• Today (8:32 CST), the best performer in the DJIA is Disney (Walt) Company. DIS.

pbs.twimg.com/media/Ggsonp1WoAEzWfr?format=jpg&name=900x900
DIS
pos_stock_hoarder pos_stock_hoarder 6 minutes ago
And truthful too! If I go to a doctor or dentist, the waiting room MAYBE has one other person besides me reading a book! And I don't mean and e-book! LOL!
STOCKMONSTER STOCKMONSTER 6 minutes ago
WORD SALAD FROM NVDA!!!!!!!!!!!!!!!!!!!!!!! NO DIRECTION!!!!!!!!! JUST A NUNCH OF INCOHERENT MUMBO JUMBO!!!!!!!!!!!!!! SORRY TO THE FOLKS WHO HAVE THEIR LIFE SAVINGS IN THIS!!!!!!!!!!!!!!!!!! POSSIBLW BREAK DOWN TO 115 BUCKS!!!!!!! MUAHAHAHHAHAH!!!!!!
NVDA
powerwalker powerwalker 6 minutes ago
Roger, what is going on with you and your ohtuvayre experience?

We would like to hear about it.
VRNA
RIGATONI RIGATONI 6 minutes ago
.074 cleared, lovely ~Rig
Starlost Starlost 6 minutes ago
Not yet...2's back on the bid...ugh.
TKMO
JamesF1 JamesF1 6 minutes ago
Purdue (Knoa) has way too much baggage to buy anything right now. Elite will be sold, but to a much better company. JMHO
ELTP
cottonmather cottonmather 6 minutes ago
Chris Vermeulen/ Market top? Good video. 23 minutes. https://youtu.be/C11ylP044AM?si=l45XaM1N7m8flt-Q
work-n-hard work-n-hard 7 minutes ago
PLUG: 3.2
NoMoDo NoMoDo 7 minutes ago
I think it is safe to say that I have read the filings. You, on the other hand are fos. The B conversions from Grado severely hurt the company, but he turned out to not be a friend or family member. He was the main guy who created the blocks tech. He took his money and ran. The biggest insider
HMBL
RobotDroid RobotDroid 7 minutes ago
The word of the day, week, and month is RED.
NWBO
BigBadWolf BigBadWolf 7 minutes ago
All need to learn [yt]Wxk1cyYJe-o[/yt]
nor converse w/ much less bring attention to any of their damn post
RDAR
AKATITUS AKATITUS 8 minutes ago
😄 🤣 😂
FUBO
TheKid5 TheKid5 8 minutes ago
Patience .....Before second quarter, for sure
CLNV
rbtree rbtree 8 minutes ago
22.20, four minutes after the open!!!
LUNR
sab63090 sab63090 8 minutes ago
boi568
He probably is correct about a second trial (I really don't know one way or the other), but surely Missling stated that he will need assistance because of the cost of that....I was always sold on: conditional approval with an ongoing trial (Phase 4).
AVXL
10thMountain 10thMountain 8 minutes ago
So what happened here?
HLLK

Your Recent History

Delayed Upgrade Clock